Scientific Abstracts

Scientific Abstracts: Intra-Arterial Therapies

Presenting Author(s)

• EA

  Erica Alexander, MD
• BC

  Brian Currie, MD
• 

  Neena Davisson, MD

  Resident Physician
  Emory University School of Medicine
• 

  Nicholas Perkons

  MD-PhD Student
  University of PA
• TS

  Tina Sankhla, MD

  Integrated Interventional Radiology Resident
  Emory University
• 

  Michael Soulen, MD

  Director Interventional Oncology, Professor of Radiology
  Abramson Cancer Center, University of Pennsylvania
• 

  Eisuke Ueshima, MD, PhD

  Assistant Professor
  Kobe University, Department of Diagnostic and Interventional Radiology

Author(s)

• ZB

  Zachary Bercu, MD, RPVI
• NF

  Nicholas Fidelman, MD
• GN

  Gregory Nadolski, MD
• HN

  Hideyuki Nishiofuku
• 

  Michael Noji

  PhD Student
  University of Pennsylvania
• AP

  Austin Pantel, MD
• KS

  Kaitlin Shinn, BA

  Medical Student
  Emory University School of Medicine
• AD

  Alexander Dabrowiecki, MD
• SF

  Sarah Friend, MD
• 

  Ricardo Garcia-Monaco, MD, PhD, FSIR

  Head of Vascular and Interventional Radiology
  Hospital Italiano de Buenos Aires
• RK

  Ryan Kiefer, MD
• RM

  Rosemarie Mick, MS
• JM

  Jeffrey Mondschein, MD
• 

  Haruyuki Takaki, MD, PhD

  Assistant Professor
  Hyogo College of Medicine
• ZB

  Zachary Bercu, MD, RPVI
• SC

  Sean Carlin, PhD
• MD

  Mandeep Dagli, MD
• YH

  Yutaka Hirata, MD, PhD
• OJ

  Omar Johnson
• EP

  Elisavet Paplomata, MD
• 

  Sarah White, MD, MS

  Associate Professor of Radiology and Surgical Oncology
  Medical College of Wisconsin
• RE

  Robert Ermentrout, MD
• HK

  Hiroshi Kodama
• GP

  Gabrielle Pilla
• DP

  Daniel Pryma, MD
• DS

  Deepak Sudheendra, MD
• EW

  E Paul Wileyto, PhD
• 

  Rony Avritscher, MD

  Associate Professor
  MD Anderson Cancer Center
• JN

  Janice Newsome, MD
• MP

  Mehrdad Pourfathi
• 

  Michael Soulen, MD

  Director Interventional Oncology, Professor of Radiology
  Abramson Cancer Center, University of Pennsylvania
• SS

  S. William Stavropoulos, MD
• TT

  Toshihiro Tanaka
• GE

  Ghassan El-Haddad, MD
• KK

  Kimihiko Kichikawa
• NK

  Nima Kokabi, MD, FRCPC
• EP

  Enri Profka
• WS

  Walid Shaib, MD
• 

  Michael Soulen, MD

  Director Interventional Oncology, Professor of Radiology
  Abramson Cancer Center, University of Pennsylvania
• DA

  Daniel Ackerman, PhD
• KC

  Kenneth Cardona, MD
• KY

  Koichiro Yamakado
• NK

  Nima Kokabi, MD, FRCPC
• GN

  Gregory Nadolski, MD
• KS

  Koji Sugimoto
• 

  Stephen Hunt, MTR, MD, PhD

  Assistant Professor
  University of Pennsylvania
• TM

  Takamichi Murakami
• 

  Terence Gade, MD, PhD

  Assistant Professor of Radiology
  Perelman School of Medicine University of Pennsylvania

Presentations:

• 7:00 AM - 8:15 AM

  In Vivo Characterization of Latent Tumor Cell Viability and Metabolism Following Transarterial Embolization in a Rat Model of Hepatocellular Carcinoma with [1-13C]-DNP-Pyruvate
  Nicholas Perkons – University of PA; Michael Noji – University of Pennsylvania; Ryan Kiefer, MD; Omar Johnson; Gabrielle Pilla; Mehrdad Pourfathi; Enri Profka; Daniel Ackerman, PhD; Gregory Nadolski, MD; Stephen Hunt, MTR, MD, PhD – University of Pennsylvania; Terence P. Gade, MD, PhD – Perelman School of Medicine University of Pennsylvania
• 7:10 AM - 7:20 AM

  Hepatic Artery Embolization Enhances the Expressions of TGF-β1 and HIF-1α in a Rat Hepatoma Model
  Eisuke Ueshima, MD, PhD – Kobe University, Department of Diagnostic and Interventional Radiology; Hideyuki Nishiofuku; Haruyuki Takaki, MD, PhD – Hyogo College of Medicine; Yutaka Hirata, MD, PhD; Hiroshi Kodama; Toshihiro Tanaka; Kimihiko Kichikawa; Koichiro Yamakado; Koji Sugimoto; Takamichi Murakami
• 7:20 AM - 7:30 AM

  Prospective Study of Systemic Yttrium-90 Elution During Radioembolization of Hepatic Metastases
  Erica Alexander, MD; Austin Pantel, MD; Rosemarie Mick, MS; Sean Carlin, PhD; Daniel Pryma, MD; Michael C. Soulen, MD – Abramson Cancer Center, University of Pennsylvania
• 7:30 AM - 7:40 AM

  Chronic Hepatotoxicity in Patients with Metastatic Neuroendocrine Tumor: TACE vs. TARE
  Brian Currie, MD; Gregory Nadolski, MD; Jeffrey Mondschein, MD; Mandeep Dagli, MD; Deepak Sudheendra, MD; S. William Stavropoulos, MD; Michael C. Soulen, MD – Abramson Cancer Center, University of Pennsylvania
• 7:40 AM - 7:50 AM

  Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET): First Safety Report
  Michael C. Soulen, MD – Abramson Cancer Center, University of Pennsylvania; Nicholas Fidelman, MD; Ricardo D. Garcia-Monaco, MD, PhD, FSIR – Hospital Italiano de Buenos Aires; Sarah B. White, MD, MS – Medical College of Wisconsin; E Paul Wileyto, PhD; Rony Avritscher, MD – MD Anderson Cancer Center; Ghassan El-Haddad, MD
• 7:50 AM - 8:00 AM

  Predictors of Survival in Chemo-refractory Colorectal Liver Metastases Treated with Y-90 Radioembolization
  Tina Sankhla, MD – Emory University; Kaitlin Shinn, BA – Emory University School of Medicine; Alexander Dabrowiecki, MD; Zachary Bercu, MD, RPVI; Robert M. Ermentrout, MD; Janice Newsome, MD; Walid Shaib, MD; Kenneth Cardona, MD; Nima Kokabi, MD, FRCPC
• 8:00 AM - 8:10 AM

  Predictors of Survival After Yttrium-90 Radioembolization of Chemo-refractory Hepatic Metastases from Breast Cancer
  Neena A. Davisson, MD – Emory University School of Medicine; Zachary Bercu, MD, RPVI; Sarah Friend, MD; Elisavet Paplomata, MD; Robert M. Ermentrout, MD; Janice Newsome, MD; Nima Kokabi, MD, FRCPC